Exact Mass: 341.1124
Exact Mass Matches: 341.1124
Found 74 metabolites which its exact mass value is equals to given mass value 341.1124,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
protodeoxyviolaceinic acid
protodeoxyviolaceinic acid
A pyrrolecarboxylic acid that is pyrrole-2-carboxylic acid which is substituted at position 3 and 5 by indol-3-yl groups.
(2,5-Dihydroxypyrrol-1-yl) 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoate
(2,5-Dihydroxypyrrol-1-yl) 5-[(3as,4S,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-D]imidazol-4-yl]pentanoic acid
(2,5-Dioxopyrrolidin-1-yl) 5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoate
(2,5-Dioxopyrrolidin-1-yl) 5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-D]imidazol-4-yl)pentanoic acid
Nep-IN-2
2-({1-hydroxy-2-[(2-methylphenyl)methyl]-3-sulphanylpropylidene}amino)-4-(methylsulphanyl)butanoic acid
3-Amino-N-[(4-methoxyphenyl)methyl]-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide
3-Amino-N-[(4-methoxyphenyl)methyl]-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide
bisindolylmaleimide v
n-methylbis(indol-3-yl)maleimide
Bisindolylmaleimide V is a cell-permeable negative control for protein kinase C inhibition studies with an IC50 value over 100 μM[1]. Bisindolylmaleimide V blocks the activation of mitogen-stimulated protein kinase p70s6k/p85s6k (S6K) in vivo with an IC50 of 8 μM[2].
Ro 31-6045
3,4-di-1H-indol-3-yl-1-methyl-1H-pyrrole-2,5-dione
Bisindolylmaleimide V is a cell-permeable negative control for protein kinase C inhibition studies with an IC50 value over 100 μM[1]. Bisindolylmaleimide V blocks the activation of mitogen-stimulated protein kinase p70s6k/p85s6k (S6K) in vivo with an IC50 of 8 μM[2].
Biotin NHS
6aR-hexahydro-2-oxo-2,5-dioxo-1-pyrrolidinyl ester-1H-thieno[3aS,4-d]imidazole-4S-pentanoic acid
9-(1H-benzimidazol-2-ylsulfinyl)-4-methoxy-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine
9-(1H-benzimidazol-2-ylsulfinyl)-4-methoxy-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine
N-methyl-1-(5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methanamine
N-methyl-1-(5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methanamine
4-TRIMETHYLAMMONIUM-2,2,6,6-TETRAMETHYLPIPERIDINE-1-OXYL IODIDE
4-TRIMETHYLAMMONIUM-2,2,6,6-TETRAMETHYLPIPERIDINE-1-OXYL IODIDE
Benzenesulfonamide,N-ethyl-4-methyl-N-(5-phenyl-2-furanyl)-
Benzenesulfonamide,N-ethyl-4-methyl-N-(5-phenyl-2-furanyl)-
VU0152100
3-Amino-N-[(4-methoxyphenyl)methyl]-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide
VU0152100 (VU152100) is a highly selective mAChR positive allosteric modulator (permeable to the blood-brain barrier). VU0152100 reverses Amphetamine-induced hypermotility in rats and increased levels of extracellular dopamine in nucleus accumbens and caudate-putamen. VU0152100 has good research potential in psychosis and cognitive impairment associated with mental disorders such as schizophrenia[1][2].
3-amino-2-nitro-1-phenyl-9,10-dihydrophenanthrene-4-carbonitrile
3-amino-2-nitro-1-phenyl-9,10-dihydrophenanthrene-4-carbonitrile
methyl (2S,3S,4S,5R,6S)-6-(4-acetamidophenoxy)-3,4,5-trihydroxyoxane-2-carboxylate
methyl (2S,3S,4S,5R,6S)-6-(4-acetamidophenoxy)-3,4,5-trihydroxyoxane-2-carboxylate
6-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)-5-CHLORONICOTINIC ACID
6-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)-5-CHLORONICOTINIC ACID
2,5-Dioxopyrrolidin-1-yl 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate
2,5-Dioxopyrrolidin-1-yl 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate
4-[1-(4-fluorophenyl)-2-nitroethyl]-5-methyl-2-phenyl-1H-pyrazol-3-one
4-[1-(4-fluorophenyl)-2-nitroethyl]-5-methyl-2-phenyl-1H-pyrazol-3-one
3,5-Dimethyl-4-[(4-methylphenyl)sulfonyl-phenylmethyl]isoxazole
3,5-Dimethyl-4-[(4-methylphenyl)sulfonyl-phenylmethyl]isoxazole
1-Hydroxy-2,2,5,5-tetramethyl-3-(methylsulfonylsulfanylmethyl)-4-phenylpyrrole
1-Hydroxy-2,2,5,5-tetramethyl-3-(methylsulfonylsulfanylmethyl)-4-phenylpyrrole
(2E)-3-{4-hydroxy-3-[(E)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-5-methoxyphenyl}prop-2-enoate
(2E)-3-{4-hydroxy-3-[(E)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-5-methoxyphenyl}prop-2-enoate
N-(6-Aminohexyl)-1-chloro-naphthalene-5-sulfonamide
N-(6-Aminohexyl)-1-chloro-naphthalene-5-sulfonamide
1-(3,5-Dimethylphenyl)-3-(4-methyl-3-oxo-1,4-benzothiazin-6-yl)urea
1-(3,5-Dimethylphenyl)-3-(4-methyl-3-oxo-1,4-benzothiazin-6-yl)urea
N-(2-furanylmethyl)-4-methyl-N-(phenylmethyl)benzenesulfonamide
N-(2-furanylmethyl)-4-methyl-N-(phenylmethyl)benzenesulfonamide
[4-(2-Methylphenyl)-1-piperazinyl]-(4-nitrophenyl)methanethione
[4-(2-Methylphenyl)-1-piperazinyl]-(4-nitrophenyl)methanethione
2-[(3-cyano-8-methyl-2-quinolinyl)thio]-N-(2-oxolanylmethyl)acetamide
2-[(3-cyano-8-methyl-2-quinolinyl)thio]-N-(2-oxolanylmethyl)acetamide
2,4,7,9-tetrahydroxy-6-methyl-8-(2-methylbut-3-en-2-yl)-1-oxo-1H-phenalen-3-ol
2,4,7,9-tetrahydroxy-6-methyl-8-(2-methylbut-3-en-2-yl)-1-oxo-1H-phenalen-3-ol
2,3,9-Trihydroxy-7-methyl-5-(2-methylbut-3-en-2-yl)-4,6-dioxophenalen-1-olate
2,3,9-Trihydroxy-7-methyl-5-(2-methylbut-3-en-2-yl)-4,6-dioxophenalen-1-olate
INDOLE-1-ACETIC ACID, 3-(p-FLUOROBENZOYL)-6-METHOXY-2-METHYL-
INDOLE-1-ACETIC ACID, 3-(p-FLUOROBENZOYL)-6-METHOXY-2-METHYL-
1-(7-methoxyquinolin-4-yl)-9h-pyrido[3,4-b]indol-3-ol
1-(7-methoxyquinolin-4-yl)-9h-pyrido[3,4-b]indol-3-ol
2-(2-hydroxy-4-methoxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)acetonitrile
2-(2-hydroxy-4-methoxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)acetonitrile
(2r)-2-(3-hydroxy-4-methoxyphenyl)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}acetonitrile
(2r)-2-(3-hydroxy-4-methoxyphenyl)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}acetonitrile
2-(3-hydroxy-4-methoxyphenyl)-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}acetonitrile
2-(3-hydroxy-4-methoxyphenyl)-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}acetonitrile
5-{[4-(2h-1,3-benzodioxol-5-ylmethyl)-1-methylimidazol-2-yl]imino}-2-hydroxy-3-methylimidazol-4-one
5-{[4-(2h-1,3-benzodioxol-5-ylmethyl)-1-methylimidazol-2-yl]imino}-2-hydroxy-3-methylimidazol-4-one
(3s,6z)-3-[2-hydroxy-2-(c-hydroxycarbonimidoylimino)ethyl]-6-(1h-indol-3-ylmethylidene)-3h-pyrazine-2,5-diol
(3s,6z)-3-[2-hydroxy-2-(c-hydroxycarbonimidoylimino)ethyl]-6-(1h-indol-3-ylmethylidene)-3h-pyrazine-2,5-diol
3-{7-methoxy-9h-pyrido[3,4-b]indole-1-carbonyl}-1h-indole
3-{7-methoxy-9h-pyrido[3,4-b]indole-1-carbonyl}-1h-indole
2-(2-hydroxy-4-methoxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)acetonitrile
2-(2-hydroxy-4-methoxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)acetonitrile
7-methoxy-1-(quinolin-4-yl)-9h-pyrido[3,4-b]indol-3-ol
7-methoxy-1-(quinolin-4-yl)-9h-pyrido[3,4-b]indol-3-ol
